Laufs U - Search Results

1

Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease.

Schunk SJ, Triem S, Schmit D, Zewinger S, Sarakpi T, Becker E, Hütter G, Wrublewsky S, Küting F, Hohl M, Alansary D, Prates Roma L, Lipp P, Möllmann J, Lehrke M, Laschke MW, Menger MD, Kramann R, Boor P, Jahnen-Dechent W, März W, Böhm M, Laufs U, Niemeyer BA, Fliser D, Ampofo E, Speer T. Schunk SJ, et al. Among authors: laufs u. Circulation. 2021 Sep 14;144(11):893-908. doi: 10.1161/CIRCULATIONAHA.121.053547. Epub 2021 Jul 1. Circulation. 2021. PMID: 34192892 Free article.

2

[New findings on the action of HMG-CoA-reductase inhibitors].

Laufs U, Böhm M, Liao JK. Laufs U, et al. Dtsch Med Wochenschr. 1997 Oct 10;122(41):1255-9. doi: 10.1055/s-2008-1047756. Dtsch Med Wochenschr. 1997. PMID: 9378055 Review. German. No abstract available.

3

[The cardiovascular risk factor in obesity].

Laufs U, Böhm M. Laufs U, et al. Dtsch Med Wochenschr. 2000 Mar 3;125(9):262-8. doi: 10.1055/s-2007-1024089. Dtsch Med Wochenschr. 2000. PMID: 10742819 Review. German. No abstract available.

4

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Böhm M. Laufs U, et al. Circulation. 2000 Dec 19;102(25):3104-10. doi: 10.1161/01.cir.102.25.3104. Circulation. 2000. PMID: 11120702

5

Withdrawal of statins increases event rates in patients with acute coronary syndromes.

Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Heeschen C, et al. Among authors: laufs u. Circulation. 2002 Mar 26;105(12):1446-52. doi: 10.1161/01.cir.0000012530.68333.c8. Circulation. 2002. PMID: 11914253

6

Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.

Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rösen R, Böhm M, Nickenig G. Wassmann S, et al. Among authors: laufs u. Circulation. 2002 Apr 30;105(17):2083-91. doi: 10.1161/01.cir.0000014618.91633.67. Circulation. 2002. PMID: 11980689

7

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.

Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M. Laufs U, et al. Brain Res. 2002 Jun 28;942(1-2):23-30. doi: 10.1016/s0006-8993(02)02649-5. Brain Res. 2002. PMID: 12031849

8

[Blood pressure increases with waist circumference].

Laufs U, Böhm M. Laufs U, et al. MMW Fortschr Med. 2002 Mar 14;144(11):43-4. MMW Fortschr Med. 2002. PMID: 12066512 German. No abstract available.

9

Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.

Wassmann S, Hilgers S, Laufs U, Böhm M, Nickenig G. Wassmann S, et al. Among authors: laufs u. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1208-12. doi: 10.1161/01.atv.0000022847.38083.b6. Arterioscler Thromb Vasc Biol. 2002. PMID: 12117739 Clinical Trial.

10

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition.

Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, Nickenig G. Werner N, et al. Among authors: laufs u. Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1567-72. doi: 10.1161/01.atv.0000036417.43987.d8. Arterioscler Thromb Vasc Biol. 2002. PMID: 12377731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters